Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anlotinib, Irinotecan, and Vincristine in Advanced Ewing Sarcoma
NCT03416517Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlotinib in Ewing sarcoma, sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
anlotinib
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on NCT03416517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03416517.